Skip to content

Clinical trials

Completed Phase 2/3 Cardiovascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2/3 Status: Completed Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20052
20062
20071
20082
20091
20102
20131
20141
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Aging (NIA)2
Rottapharm Spain2
Augusta University1
Beni-Suef University1
Isfahan University of Medical Sciences1
Laval University1
Lund University1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Parke-Davis1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases20
Atherosclerosis5
Diabetes Mellitus, Type 24
Diabetes Mellitus3
Coronary Artery Disease2
Insulin Resistance2
Obesity2
Stroke2
Aneurysm1
Asthma1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.